Showing results (221-230 of 262) with videos related to
Sort By:
Pageof 27
Thyroid : Official Journal of the American Thyroid Association|January 8, 2020
Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in KoreaEyun Song, Mijin Kim, Eui Young Kim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2015
Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer CellsThoudam Debraj Singh, Shin Young Jeong, Sang-Woo Lee, et al.Experimental Cell Research|January 9, 2023
Mesenchymal stromal cell therapy for patients with rheumatoid arthritisBushu Harna, Pulkit Kalra, Shivali Arya, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 16, 2018
In vivo migration of mesenchymal stem cells to burn injury sites and their therapeutic effects in a living mouse modelEun Jung Oh, Ho Won Lee, Senthilkumar Kalimuthu, et al.International Journal of Molecular Sciences|September 13, 2025
Correction: Kalimuthu et al. Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical Imaging. Int. J. Mol. Sci. 2018, 19, 1002Senthilkumar Kalimuthu, Liya Zhu, Ji Min Oh, et al.Stem Cells International|December 14, 2020
Corrigendum to "In Vivo Tracking of Chemokine Receptor CXCR4-Engineered Mesenchymal Stem Cell Migration by Optical Molecular Imaging"Senthilkumar Kalimuthu, Ji Min Oh, Prakash Gangadaran, et al.International Journal of Molecular Sciences|March 28, 2018
Regulated Mesenchymal Stem Cells Mediated Colon Cancer Therapy Assessed by Reporter Gene Based Optical ImagingSenthilkumar Kalimuthu, Liya Zhu, Ji Min Oh, et al.Clinical Nuclear Medicine|July 24, 2018
Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent ChemoradiotherapySeung Hyun Son, Shin Young Jeong, Gun Oh Chong, et al.Oncotarget|February 23, 2018
Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene systemJi Min Oh, Senthilkumar Kalimuthu, Prakash Gangadaran, et al.Journal of Drug Targeting|March 20, 2020
A new tyrosine kinase inhibitor K905-0266 inhibits proliferation and sphere formation of glioblastoma cancer cellsSenthilkumar Kalimuthu, Prakash Gangadaran, Ji Min Oh, et al.Pageof 27